From: Investigation of the efficacy of the short regimen for rifampicin-resistant TB from the STREAM trial
Hazard ratio with 95% CI | |
---|---|
Unadjusted, assuming independent censoring | 2.19 (0.90, 5.35) |
Adjusted for baseline covariates, assuming independent censoring | 2.14 (0.87, 5.26) |
Adjusted, using IPCW with time varying covariates | 2.41 (0.92, 6.29) |
Adjusted, using IPCW with no time varying covariates | 1.96 (0.75, 5.14) |